Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Moodys
Chubb
Cerilliant
Teva
QuintilesIMS
Healthtrust
McKesson
Merck
Johnson and Johnson

Generated: October 21, 2017

DrugPatentWatch Database Preview

Suppliers and packages for generic ingredient: ibrutinib

« Back to Dashboard

Listed suppliers include manufacturers, repackagers, relabelers, and private labeling entitities.

Applicant Tradename Generic Name Dosage NDA NDA/ANDA Supplier Package Code Package
Pharmacyclics Inc
IMBRUVICA
ibrutinib
CAPSULE;ORAL205552NDAPharmacyclics LLC57962-140-0990 CAPSULE in 1 BOTTLE, PLASTIC (57962-140-09)
Pharmacyclics Inc
IMBRUVICA
ibrutinib
CAPSULE;ORAL205552NDAPharmacyclics LLC57962-140-12120 CAPSULE in 1 BOTTLE, PLASTIC (57962-140-12)
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Queensland Health
Farmers Insurance
Covington
McKesson
UBS
Chinese Patent Office
Novartis
US Department of Justice
Cerilliant
US Army

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot